Physician profile
Derek Mark Evans
NPI 1114365129
$1,381.48
in general payments reported to CMS, 2019-2025
19 companies · $628 in 2025
The $628 reported for 2025 was more than what 83% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $315 · 2021: $16.74 · 2022: $97.02 · 2023: $173 · 2024: $152 · 2025: $628.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $925 · Honoraria: $27.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $924.77 |
| Honoraria | $27.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $227.38 | 2019-2025 | Rocklatan, Clareon, Tryptyr |
| Sun Pharmaceutical Industries INC. | $221.02 | 2019-2025 | Cequa |
| Tarsus Pharmaceuticals, INC. | $140.48 | 2024-2025 | Xdemvy |
| Rxsight INC | $130.25 | 2023-2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Injector Handpiece |
| Bausch & Lomb Americas INC. | $118.27 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Abbvie INC. | $111.03 | 2024-2025 | |
| Apellis Pharmaceuticals, INC. | $75.77 | 2025 | Syfovre |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $62.33 | 2019 | |
| Dompe US, INC. | $60.55 | 2025 | Oxervate |
| Coopervision INC. | $43.81 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $35.38 | 2019 | |
| Glaukos Corporation | $31.12 | 2025 | Idosetr |
| Allergan, INC. | $24.06 | 2019 | |
| Harrow Eye, LLC | $23.41 | 2025 | Vevye |
| Novartis Pharmaceuticals Corporation | $18.69 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $17.50 | 2022 | |
| Shire North American Group INC | $15.18 | 2019 | |
| Rayner Intraocular Lenses Limited | $14.93 | 2025 | Omidria |
| Oasis Medical, INC. | $10.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.